145 related articles for article (PubMed ID: 28688199)
21. CpG demethylation in the neurotoxicity of 1-methyl-4-phenylpyridinium might mediate transcriptional up-regulation of α-synuclein in SH-SY5Y cells.
Yang J; Yang Z; Wang X; Sun M; Wang Y; Wang X
Neurosci Lett; 2017 Oct; 659():124-132. PubMed ID: 28807729
[TBL] [Abstract][Full Text] [Related]
22. Neurotoxin-induced pathway perturbation in human neuroblastoma SH-EP cells.
Do JH
Mol Cells; 2014 Sep; 37(9):672-84. PubMed ID: 25234470
[TBL] [Abstract][Full Text] [Related]
23. Carnosic acid protects SH-SY5Y cells against 6-hydroxydopamine-induced cell death through upregulation of parkin pathway.
Lin CY; Tsai CW; Tsai CW
Neuropharmacology; 2016 Nov; 110(Pt A):109-117. PubMed ID: 27091487
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
[TBL] [Abstract][Full Text] [Related]
25. USP30 inhibition induces mitophagy and reduces oxidative stress in parkin-deficient human neurons.
Okarmus J; Agergaard JB; Stummann TC; Haukedal H; Ambjørn M; Freude KK; Fog K; Meyer M
Cell Death Dis; 2024 Jan; 15(1):52. PubMed ID: 38225227
[TBL] [Abstract][Full Text] [Related]
26. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
[TBL] [Abstract][Full Text] [Related]
27. Parkinson's disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids.
Appukuttan TA; Ali N; Varghese M; Singh A; Tripathy D; Padmakumar M; Gangopadhyay PK; Mohanakumar KP
J Neurosci Res; 2013 Jul; 91(7):963-70. PubMed ID: 23653325
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
[TBL] [Abstract][Full Text] [Related]
29. Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease.
Sun X; Aimé P; Dai D; Ramalingam N; Crary JF; Burke RE; Greene LA; Levy OA
Exp Neurol; 2018 May; 303():95-107. PubMed ID: 29432724
[TBL] [Abstract][Full Text] [Related]
30. Carnosic Acid Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells by Inducing Autophagy Through an Enhanced Interaction of Parkin and Beclin1.
Lin CY; Tsai CW
Mol Neurobiol; 2017 May; 54(4):2813-2822. PubMed ID: 27013469
[TBL] [Abstract][Full Text] [Related]
31. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease.
Fukae J; Sato S; Shiba K; Sato K; Mori H; Sharp PA; Mizuno Y; Hattori N
FEBS Lett; 2009 Feb; 583(3):521-5. PubMed ID: 19146857
[TBL] [Abstract][Full Text] [Related]
32. Extremely Low Frequency Magnetic Field (ELF-MF) Exposure Sensitizes SH-SY5Y Cells to the Pro-Parkinson's Disease Toxin MPP(.).
Benassi B; Filomeni G; Montagna C; Merla C; Lopresto V; Pinto R; Marino C; Consales C
Mol Neurobiol; 2016 Aug; 53(6):4247-4260. PubMed ID: 26223801
[TBL] [Abstract][Full Text] [Related]
33. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS
Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198
[TBL] [Abstract][Full Text] [Related]
34. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
Xie HR; Hu LS; Li GY
Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
[TBL] [Abstract][Full Text] [Related]
35. 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach.
Magalingam KB; Somanath SD; Ramdas P; Haleagrahara N; Radhakrishnan AK
J Mol Neurosci; 2022 May; 72(5):1026-1046. PubMed ID: 35258800
[TBL] [Abstract][Full Text] [Related]
36. RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells.
Bando Y; Katayama T; Taniguchi M; Ishibashi T; Matsuo N; Ogawa S; Tohyama M
Neurobiol Dis; 2005 Feb; 18(1):143-51. PubMed ID: 15649705
[TBL] [Abstract][Full Text] [Related]
37. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations.
Gautier CA; Erpapazoglou Z; Mouton-Liger F; Muriel MP; Cormier F; Bigou S; Duffaure S; Girard M; Foret B; Iannielli A; Broccoli V; Dalle C; Bohl D; Michel PP; Corvol JC; Brice A; Corti O
Hum Mol Genet; 2016 Jul; 25(14):2972-2984. PubMed ID: 27206984
[TBL] [Abstract][Full Text] [Related]
38. The mitochondrial protein BNIP3L is the substrate of PARK2 and mediates mitophagy in PINK1/PARK2 pathway.
Gao F; Chen D; Si J; Hu Q; Qin Z; Fang M; Wang G
Hum Mol Genet; 2015 May; 24(9):2528-38. PubMed ID: 25612572
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins.
Tieu K; Zuo DM; Yu PH
J Neurosci Res; 1999 Nov; 58(3):426-35. PubMed ID: 10518116
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration.
Sul JW; Park MY; Shin J; Kim YR; Yoo SE; Kong YY; Kwon KS; Lee YH; Kim E
Hum Mol Genet; 2013 Apr; 22(8):1558-73. PubMed ID: 23307929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
